A Strategic and Worldwide Cooperative Challenge Required for the Next Generation of Platelet Concentrates
Acknowledgments
Conflicts of Interest
References
- Kawase, T. Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: Basic principles and concepts underlying recent advances. Odontology 2015, 103, 126–135. [Google Scholar] [CrossRef] [PubMed]
- Kawase, T.; Mubarak, S.; Mourão, C.F. The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future. Bioengineering 2020, 7, 82. [Google Scholar] [CrossRef] [PubMed]
- Aizawa, H.; Tsujino, T.; Watanabe, T.; Isobe, K.; Kitamura, Y.; Sato, A.; Yamaguchi, S.; Okudera, H.; Okuda, K.; Kawase, T. Quantitative Near-Infrared Imaging of Platelets in Platelet-Rich Fibrin (PRF) Matrices: Comparative Analysis of Bio-PRF, Leukocyte-Rich PRF, Advanced-PRF and Concentrated Growth Factors. Int. J. Mol. Sci. 2020, 21, 4426. [Google Scholar] [CrossRef] [PubMed]
- Devereaux, J.; Dargahi, N.; Fraser, S.; Nurgali, K.; Kiatos, D.; Apostolopoulos, V. Leucocyte-Rich Platelet-Rich Plasma Enhances Fibroblast and Extracellular Matrix Activity: Implications in Wound Healing. Int. J. Mol. Sci. 2020, 21, 6519. [Google Scholar] [CrossRef]
- Nakama, G.Y.; Gonzalez, S.; Matre, P.; Mu, X.; Whitney, K.E.; Utsunomiya, H.; Arner, J.W.; Philippon, M.J.; Ravuri, S.; Huard, J. Effect of Oral Losartan on Orthobiologics: Implications for Platelet-Rich Plasma and Bone Marrow Concentrate—A Rabbit Study. Int. J. Mol. Sci. 2020, 21, 7374. [Google Scholar] [CrossRef]
- Al-Maawi, S.; Dohle, E.; Lim, J.; Weigl, P.; Teoh, S.H.; Sader, R.; Ghanaati, S. Biologization of Pcl-Mesh Using Platelet Rich Fibrin (Prf) Enhances Its Regenerative Potential In Vitro. Int. J. Mol. Sci. 2021, 22, 2159. [Google Scholar] [CrossRef]
- Olmos Calvo, I.; Kuten-Pella, O.; Kramer, K.; Madár, Á.; Takács, S.; Kardos, D.; Simon, D.; Erdö-Bonyár, S.; Berki, T.; De Luna, A.; et al. Optimization of Lyophilized Hyperacute Serum (HAS) as a Regenerative Therapeutic in Osteoarthritis. Int. J. Mol. Sci. 2021, 22, 7496. [Google Scholar] [CrossRef] [PubMed]
- Egle, K.; Salma, I.; Dubnika, A. From Blood to Regenerative Tissue: How Autologous Platelet-Rich Fibrin Can Be Combined with Other Materials to Ensure Controlled Drug and Growth Factor Release. Int. J. Mol. Sci. 2021, 22, 11553. [Google Scholar] [CrossRef]
- Kawase, T.; Okuda, K. Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan. Biomed. Res. Int. 2018, 2018, 6389157. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kawase, T. A Strategic and Worldwide Cooperative Challenge Required for the Next Generation of Platelet Concentrates. Int. J. Mol. Sci. 2022, 23, 3437. https://doi.org/10.3390/ijms23073437
Kawase T. A Strategic and Worldwide Cooperative Challenge Required for the Next Generation of Platelet Concentrates. International Journal of Molecular Sciences. 2022; 23(7):3437. https://doi.org/10.3390/ijms23073437
Chicago/Turabian StyleKawase, Tomoyuki. 2022. "A Strategic and Worldwide Cooperative Challenge Required for the Next Generation of Platelet Concentrates" International Journal of Molecular Sciences 23, no. 7: 3437. https://doi.org/10.3390/ijms23073437